We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$128M
Cap. Flow
+$26.2M
Cap. Flow %
2.17%
Top 10 Hldgs %
56.76%
Holding
362
New
28
Increased
88
Reduced
207
Closed
28

Top Buys

Rank Stock Value
1
TME icon
Tencent Music
TME
+$28.3M
2
LEGN icon
Legend Biotech
LEGN
+$20.2M
3
TCOM icon
Trip.com Group
TCOM
+$16M
4
STAA icon
STAAR Surgical
STAA
+$10.7M
5
ZLAB icon
Zai Lab
ZLAB
+$7.74M

Top Sells

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$21.9M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
3
NIO icon
NIO
NIO
+$10.3M
4
LI icon
Li Auto
LI
+$8.53M
5
BZ icon
Kanzhun
BZ
+$8.18M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Technology 25.51%
3 Communication Services 14.94%
4 Healthcare 9.44%
5 Real Estate 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EBAY icon
251
eBay
EBAY
$48.6B
$259K 0.02%
6,236
-223
-3% -$9.24K
JD icon
252
JD.com
JD
$40.8B
$259K 0.02%
4,615
-1,888
-29% -$95K
BBIO icon
253
BridgeBio Pharma
BBIO
$16.5B
$258K 0.02%
33,826
+476
+1% +$4.56K
EBS icon
254
Emergent Biosolutions
EBS
$375M
$257K 0.02%
21,766
+5,618
+35% +$86.9K
BHVN icon
255
Biohaven
BHVN
$2.16B
$256K 0.02%
18,474
+15,241
+471% +$215K
KRYS icon
256
Krystal Biotech
KRYS
$9.88B
$256K 0.02%
3,228
-363
-10% -$26.9K
INBX
257
DELISTED
Inhibrx, Inc. Common Stock
INBX
$254K 0.02%
+10,315
New +$303K
T icon
258
AT&T
T
$165B
$252K 0.02%
13,702
-461
-3% -$8.25K
BDX icon
259
Becton Dickinson
BDX
$43.1B
$251K 0.02%
986
-76
-7% -$17.9K
ALLO icon
260
Allogene Therapeutics
ALLO
$601M
$249K 0.02%
39,645
+8,037
+25% +$74.4K
UNP icon
261
Union Pacific
UNP
$183B
$247K 0.02%
1,191
-52
-4% -$10.7K
UPS icon
262
United Parcel Service
UPS
$97.6B
$245K 0.02%
1,408
-74
-5% -$12.8K
GLW icon
263
Corning
GLW
$126B
$244K 0.02%
7,638
– –
SCHW
264
Charles Schwab
SCHW
$177B
$244K 0.02%
2,936
-156
-5% -$12.1K
CAT icon
265
Caterpillar
CAT
$409B
$243K 0.02%
+1,016
New +$221K
CDW icon
266
CDW
CDW
$17.1B
$242K 0.02%
1,357
– –
ZNTL icon
267
Zentalis Pharmaceuticals
ZNTL
$308M
$242K 0.02%
12,016
-612
-5% -$13.2K
VCEL icon
268
Vericel Corp
VCEL
$2.3B
$241K 0.02%
9,131
-570
-6% -$13.6K
LOW icon
269
Lowe's Companies
LOW
$116B
$239K 0.02%
1,202
-106
-8% -$21.2K
KDNY
270
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$239K 0.02%
+9,117
New +$202K
HPQ icon
271
HP
HPQ
$23.5B
$238K 0.02%
8,859
-389
-4% -$10.8K
ARQT icon
272
Arcutis Biotherapeutics
ARQT
$3.42B
$235K 0.02%
15,880
+3,933
+33% +$68.7K
BSX icon
273
Boston Scientific
BSX
$65.8B
$235K 0.02%
5,070
-805
-14% -$34.9K
QURE icon
274
uniQure
QURE
$2.68B
$235K 0.02%
10,350
-4,120
-28% -$88.9K
ZTS icon
275
Zoetis
ZTS
$31.6B
$234K 0.02%
1,599
-126
-7% -$18.6K
9 10
11
12 13

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, E Fund Management held 362 positions worth $1.2B, up 12% from $1.07B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

E Fund Management's Q4 2022 filing shows 28 new, 88 increased, 207 reduced and 28 closed positions. Its largest new stake was Akero Therapeutics: 9,604 shares worth $526K. The largest sale was KE Holdings, an estimated $21.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q4 2022 buy was Akero Therapeutics: 9,604 shares worth $526K.
  • E Fund Management added most to Tencent Music in Q4 2022, an estimated $28.3M increase.
  • E Fund Management's biggest Q4 2022 reduction was KE Holdings, cutting an estimated $21.9M.
  • E Fund Management fully exited Li Auto in Q4 2022, selling an estimated $8.53M.
  • E Fund Management's ten largest holdings make up 57% of its $1.2B portfolio in Q4 2022.
  • E Fund Management opened 28 new positions and closed 28 in Q4 2022.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.2B.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.